Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer

Retinoic acid receptor B2 (RARB2) is frequently inactivated in cancer. Methylation in the 5′‐untranslated region and first exon is known to play a role; however, few studies have analyzed the detailed methylation pattern of the promoter region. We show that hypo‐ and hypermethylated alleles coexist in 5/11 cell lines in which RARB2 is inactivated. We present evidence supporting the mitotic transmission of these divergent methylation patterns and find a correlation between methylation divergence and heterozygosity at the 3p24 loci, suggesting an allelic methylation bias in these lines. Using a newly devised strategy based on allelic identification via methylation‐sensitive restriction enzyme digestion combined with the use of a single nucleotide polymorphism, rs755661, we demonstrate that such a bias exists in three cancer cell specimens heterozygous at rs755661 and therefore amenable to this study. This previously unreported phenomenon of allelic methylation bias suggests that a promoter methylation‐independent mechanism may be responsible for inactivation at the hypomethylated allele and this inactivation is reminiscent of an aberrant form of de novo imprinting. Approaches to interpreting methylation data should incorporate the notion of allelic methylation bias. © 2008 Wiley‐Liss, Inc.

[1]  J. den Hertog,et al.  Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness. , 1991, DNA sequence : the journal of DNA sequencing and mapping.

[2]  J. Knoll,et al.  Allele specificity of DNA replication timing in the Angelman/Prader–Willi syndrome imprinted chromosomal region , 1994, Nature Genetics.

[3]  J. Trasler Origin and roles of genomic methylation patterns in male germ cells. , 1998, Seminars in cell & developmental biology.

[4]  J. Minna,et al.  Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.

[5]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Bird,et al.  Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein. , 1992, The EMBO journal.

[7]  R. Momparler,et al.  Quantitation of inhibition of DNA methylation of the retinoic acid receptor beta gene by 5-Aza-2'-deoxycytidine in tumor cells using a single-nucleotide primer extension assay. , 2000, Analytical biochemistry.

[8]  A. Chess,et al.  Asynchronous replication and allelic exclusion in the immune system , 2001, Nature.

[9]  H. Tsou,et al.  Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .

[10]  C. Clarke,et al.  Expression and regulation of retinoic acid receptors in human breast cancer cells. , 1992, Cancer research.

[11]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[12]  M. Fackler,et al.  DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.

[13]  P. Jones,et al.  The DNA methylation paradox. , 1999, Trends in genetics : TIG.

[14]  Alexander Dobrovic,et al.  Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. , 2002, Carcinogenesis.

[15]  D. Sugarbaker,et al.  High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.

[16]  C. Croce,et al.  Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. , 2003, Cancer research.

[17]  V. Seewaldt,et al.  Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. , 1997, Experimental cell research.

[18]  B. Houle,et al.  Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines. , 1994, Cancer research.

[19]  A. Chess,et al.  Coordination of the random asynchronous replication of autosomal loci , 2003, Nature Genetics.

[20]  A. Chess Monoallelic expression of protocadherin genes , 2005, Nature Genetics.

[21]  M. Tsao,et al.  Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. , 1994, Experimental cell research.

[22]  P. Chambon,et al.  Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. , 1991, Experimental cell research.

[23]  J. Minna,et al.  Human lung cancer cell lines exhibit resistance to retinoic acid treatment. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  J. Minna,et al.  DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.

[25]  R. Pili,et al.  Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. , 2002, Cancer research.

[26]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[27]  A. Chess,et al.  Monoallelic Expression and Asynchronous Replication of p120 Catenin in Mouse and Human Cells* , 2005, Journal of Biological Chemistry.

[28]  B. Neel,et al.  Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer , 1995, Molecular and cellular biology.

[29]  I. Simon,et al.  Allelic inactivation regulates olfactory receptor gene expression , 1994, Cell.

[30]  M. Widschwendter,et al.  Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. , 1997, Cancer research.

[31]  D. Sinnett,et al.  DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. , 1999, Anti-cancer drugs.

[32]  R. Momparler,et al.  Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells , 2001, Cancer Chemotherapy and Pharmacology.

[33]  C. Carpenter,et al.  DNA methylation analysis: a powerful new tool for lung cancer diagnosis , 2002, Oncogene.

[34]  C. Glass,et al.  Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.

[35]  S. Sukumar,et al.  Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.

[36]  Y. Bang,et al.  Methylation of specific CpG sites in the promoter region could significantly down‐regulate p16INK4a expression in gastric adenocarcinoma , 2000, International journal of cancer.

[37]  M. Mansukhani,et al.  Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.

[38]  M. Surani,et al.  Imprinting and the Epigenetic Asymmetry Between Parental Genomes , 2001, Science.

[39]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[40]  M. Basik,et al.  Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalance. , 2003, Cancer research.

[41]  J. Minna,et al.  Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. , 2001, Cancer research.

[42]  D. Higgs,et al.  The pattern of replication at a human telomeric region (16p13.3): its relationship to chromosome structure and gene expression. , 1999, Human molecular genetics.

[43]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[44]  A. Dobrovic,et al.  erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma. , 1988, Cancer research.

[45]  G. Deng,et al.  Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer , 2002, British Journal of Cancer.

[46]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[47]  A. Dobrovic,et al.  A frequent HindIII RFLP on chromosome 3p21-25 detected by a genomic erbA beta sequence. , 1988, Nucleic acids research.

[48]  D. Sinnett,et al.  Demethylation by 5-aza-2´-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ß gene in human colon carcinoma cells , 1998, Anti-cancer drugs.

[49]  Christopher B Umbricht,et al.  Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR , 2001, The Lancet.

[50]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[51]  Y. Kuppumbatti,et al.  Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells , 2000, Oncogene.

[52]  A. Friedl,et al.  Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. , 2000, Cancer research.

[53]  R. Momparler,et al.  Activation of the retinoic acid receptor β gene by 5-aza-2’-deoxycytidine in human DLD-1 colon carcinoma cells , 1997, Anti-cancer drugs.

[54]  B. Houle,et al.  Implication of RARB in Epidermoid (Squamous) Lung Cancer , 1991, Genes, chromosomes & cancer.

[55]  J. Herman,et al.  p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. , 1999, Blood.

[56]  J. Minna,et al.  Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer , 1987, Nature.

[57]  S. Hirohashi,et al.  Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. , 2002, Nucleic acids research.